However, these measures were often insufficient for achieving significant long-term body weight loss, and many patients experienced plateauing weight loss or struggled with weight regain after treatment discontinuation
Endocrinology and Metabolism Clinics of North America , 51 (2), 273-289
The medication was approved by the FDA for weight management under the brand name Zepbound in 2023, and clinical data shows patients lost approximately 22% of their body weight over 68 weekssignificantly more than semaglutide alone
Inhibits absorption of dietary fats Dosage : 120mg capsule taken orally 2.5 MG Tirzepatide Injection Minimum Order Quantity : 100 Packs Physical Form : Other, Injection Drug Type : Other, Peptidebased antidiabetic injection Function : Other, Blood sugar control in type 2 diabetes Dosage : 2.5 mg per injection
As healthcare systems shift toward decentralized care models, demand for GLP-1 therapies delivered directly to patients residences continues to rise